Additionally, UCHL-1 seems to contribute to the protective effect of H2S. Our findings suggest that NETs formation is involved in the pathogenesis of IBD, and H2S, through the inhibition of NETs formation, provides a potential therapeutic option against IBD. Here, UCHL1 is linked to inflammatory bowel disease.